ClinicalTrials.govpublic full text
Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne Vulgaris
acne vulgaris, acne, c. acnes, vaccine, dose escalation, first in human, fih, skin microbiome, placebo, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803368
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.